HopeStage
Back to all studies
SuspendedNCT04973930

Feasibility Trial of Tele-IPT and Tele-Pharmacotherapy for Patients With Depression and Non-Metastatic Breast Cancer

Medication studyAges 18–80United States
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 80 years.

Listed locations
New YorkSee all locations and recruitment
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: March 1, 2022
Recruitment status
Suspended
Enrollment listed in the registry
20
Sponsor
New York State Psychiatric Institute
Sponsor type
Research institute
Study type
Behavioral
Intervention type
Behavioural, Drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States
Age range
From 18 Years to 80 Years
Official registry ID
NCT04973930
Official title
Show the full official title

Pilot Randomized Feasibility Trial of Tele-Interpersonal Psychotherapy and Tele-Pharmacotherapy for Depression in Patients With Non-Metastatic Breast Cancer

Recruitment & locations

Suspended

New York

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is New York State Psychiatric Institute, a research institute.

Does this study involve medication?

Yes. The study involves medication, including Venlafaxine HCl ER.

Who can participate?

Listed age limits: 18 years to 80 years.

Is this study still recruiting?

The registry lists this study as suspended.

Want to explore more studies?

Explore studies